SMID-Cap Biotech Analyst

A leading life sciences-focused investment platform is seeking an exceptional Analyst or Associate to join its team, with a primary focus on SMID‑cap biotechnology companies developing innovative therapeutics. The ideal candidate will bring buy‑side experience and a strong scientific and analytical foundation, enabling them to evaluate both clinical‑stage and commercial‑stage biotech opportunities with depth and independent judgment.

Responsibilities

• Conduct deep fundamental research on SMID‑cap biotech companies developing therapeutics across targeted indications, including cell and gene therapy, oncology, rare diseases, and other emerging treatment modalities.
• Evaluate companies across both clinical (trial design, endpoints, mechanisms of action, regulatory strategy) and commercial (market opportunity, pricing, adoption dynamics, competitive landscape) dimensions.
• Build and maintain detailed financial models, including revenue forecasts, scenario analyses, and probability‑adjusted valuations.
• Track key clinical, regulatory, and commercial catalysts and assess potential impact on investment theses.
• Synthesize scientific, clinical, and financial insights into clear, actionable investment recommendations.
• Contribute to a long‑term, fundamentals‑driven investment strategy within the public equity markets.

Requirements:

• Buy‑side experience required, ideally within a biotech‑focused long-only, long/short, or crossover investment environment.
• Experience covering therapeutics‑focused biotech companies, with demonstrated depth in scientific and clinical diligence.
• Comfort evaluating both early‑stage clinical programs and commercial‑stage companies.
• Strong ability to interpret clinical data, understand regulatory pathways, and assess competitive moats.
• Proficient financial modeling skills and familiarity with biotech valuation frameworks.
• Intellectual curiosity, humility, and the ability to form independent, evidence‑based views.
• Deep expertise in one or more therapeutic areas or modalities (e.g., gene therapy, cell therapy, oncology, neurology, rare disease).
• Ability to challenge consensus and think independently.
• Strong written and verbal communication skills.
• Passion for biotech innovation and long‑duration investing.